CONMED Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CONMED Corporation on September 16, 2024. The report discloses a material change in the Company's senior financial leadership structure effective late September 2024.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure: Eric B. Staves, Vice President and Corporate Controller, notified the Company on September 16, 2024, of his intent to leave effective September 27, 2024, to pursue an executive opportunity.
- Interim Appointment: Kimberly A. Lockwood, Director of Financial Reporting & Controls, will serve as Interim Corporate Controller effective September 30, 2024.
- Role Assumption: Todd W. Garner, Executive Vice President of Finance and Chief Financial Officer, will assume the role of Principal Accounting Officer.
- Advisory Support: Terence M. Berge, retired Vice President and Corporate Controller, will continue as Special Advisor to support the transition.
Outlook, Risks, and Management Commentary
The filing does not provide updated financial guidance, outlook, or specific risk factors beyond the operational transition of the accounting function. Management commentary is limited to the biographical background of Ms. Lockwood, noting her tenure since 2005, prior experience at PricewaterhouseCoopers LLP, and status as a certified public accountant.
Key Facts for Investor Verification
- Verify the effective dates of the leadership transition (September 27 and September 30, 2024).
- Confirm the qualifications and tenure of the Interim Corporate Controller, Kimberly A. Lockwood.
- Monitor future filings for the appointment of a permanent Corporate Controller.
- Review upcoming quarterly reports (10-Q) for any impact on financial reporting timelines or internal controls due to this transition.